Cases 1 - 6 of 6
Alnylam Pharmaceuticals, Inc. v. Silence Therapeutics GmbH et al
as 1:2018cv10613
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Silence Therapeutics GmbH and Silence Therapeutics plc
Cause Of Action: 28 U.S.C. § 2201
Alnylam Pharmaceuticals, Inc. v. Silence Therapeutics plc et al
as 1:2018cv10612
Plaintiff:
Alnylam Pharmaceuticals, Inc.
Defendant:
Silence Therapeutics plc and Silence Therapeutics GmbH
Cause Of Action: 28 U.S.C. § 2201 Declaratory Judgment
Dicerna Pharmaceuticals, Inc. v. Alnylam Pharmaceuticals, Inc.
as 1:2017cv11466
Plaintiff:
Dicerna Pharmaceuticals, Inc.
Defendant:
Alnylam Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 2
Alnylam Pharmaceuticals, Inc. et al V. Tekmira Pharmaceuticals Corporation
as 1:2012cv10087
Plaintiff:
Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals Inc.
Defendant:
Tekmira Pharmaceuticals Corporation
Cause Of Action: 15 U.S.C. § 1126
University of Utah v. Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften e.V. et al
as 1:2011cv10484
Defendant:
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften e.V., Max-Planck-Innovation GmbH, Whitehead Institute for Biomedical Research and others
Plaintiff:
University of Utah
Cause Of Action: 28 U.S.C. § 2201
Max-Planck-Gesellschaft zur Frderung der Wissenschaften e.V. et al v. Whitehead Institute for Biomedical Research et al
as 1:2009cv11116
Plaintiff:
Max-Planck-Gesellschaft zur Frderung der Wissenschaften e.V., Max-Planck-Gesellschaft zur Frderung der Wissenschaften e.V., Max-Planck-Innovation GmbH and others
Defendant:
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology and Board of Trustees of the University of Massachusetts
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
